跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUPIN-CEPHALEXIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LUPIN-CEPHALEXIN
Authorized
STANDARD
LUPIN-CEPHALEXIN
lupin pharma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4556224d5aa599b3
Company
lupin pharma canada limited
Type
Standard
Approval Details
Approval Id
4556224d5aa599b3
Drug Approval Canada Name
LUPIN-CEPHALEXIN
Product Name
LUPIN-CEPHALEXIN
Status
Marketed
Status Date
2018-12-04
Original Market Date
2018-12-04
Din
02469170
Drug Class
Human
Dosage Form
Powder For Suspension
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.06.04
Atc Original
J01DB01 CEFALEXIN
Atc Name
j 01 db 01
Aig Number
0105911001
Company Name
lupin pharma canada limited
Company Address
550-1111 Rue St-Charles Ouest, Longueuil, Quebec, Canada, J4K 5G4
Active Ingredients
CEPHALEXIN (CEPHALEXIN MONOHYDRATE)
125 MG / 5 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4556224d5aa599b3
Type
Standard
Back to Health Canada Approvals